Cargando…

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons

Liver disease is a leading cause of mortality among HIV-infected persons in the highly active anti-retroviral therapy (HAART) era. Hepatitis C Virus (HCV) co-infection is prevalent in, and worsened by HIV; consequently many co-infected persons require liver transplantation (LT). Despite the need, po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balagopal, Ashwin, Barin, Burc, Quinn, Jeffrey, Rogers, Rodney, Sulkowski, Mark S., Stock, Peter G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551738/ https://www.ncbi.nlm.nih.gov/pubmed/26313939 http://dx.doi.org/10.1371/journal.pone.0135882

Ejemplares similares

HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 Decline
por: Quinn, Jeffrey, et al.
Publicado: (2017)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

Therapeutic issues in HIV/HCV-coinfected patients
por: Sulkowski, M S, et al.
Publicado: (2007)

Glances in Immunology of HIV and HCV Infection
por: Quaranta, Maria Giovanna, et al.
Publicado: (2012)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment
por: Grudda, Tanner, et al.
Publicado: (2022)

2232. Zinc deficiency and advanced liver fibrosis among HIV/HCV co-infected persons in Russia
por: Barocas, Joshua, et al.
Publicado: (2018)

2549. Variance Between Clinicians and Guidelines in Management of HIV/HCV Coinfection
por: Naggie, Susanna, et al.
Publicado: (2019)

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
por: Bulfoni, Michela, et al.
Publicado: (2021)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
por: Gobran, Samaa T., et al.
Publicado: (2021)

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile
por: Dalla, Emiliano, et al.
Publicado: (2022)

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients
por: Sawinski, Deirdre, et al.
Publicado: (2015)

HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection
por: Vali, Bahareh, et al.
Publicado: (2008)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Are T cells the only HIV-1 reservoir?
por: Kandathil, Abraham Joseph, et al.
Publicado: (2016)

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
por: Farcomeni, Stefania, et al.
Publicado: (2021)

Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients
por: El Awady, Mostafa K., et al.
Publicado: (2014)

Erratum to: Are T cells the only HIV-1 reservoir?
por: Kandathil, Abraham Joseph, et al.
Publicado: (2017)

HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients
por: Abravanel, Florence, et al.
Publicado: (2012)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Inferring Viral Dynamics in Chronically HCV Infected Patients from the Spatial Distribution of Infected Hepatocytes
por: Graw, Frederik, et al.
Publicado: (2014)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
por: Marino, Andrea, et al.
Publicado: (2021)

Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects
por: Zuccalà, Paola, et al.
Publicado: (2022)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

P Selectins and immunological profiles in HCV and Schistosoma mansoni induced chronic liver disease
por: Kamel, Mahmoud M, et al.
Publicado: (2014)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study
por: Barin, Burc, et al.
Publicado: (2022)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Immunological HCV-Associated Thrombocytopenia: Short Review
por: Dimitroulis, Dimitrios, et al.
Publicado: (2012)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Intravenous drug use – an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients
por: Salemovic, Dubravka, et al.
Publicado: (2017)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study
por: Ward, Kathleen M, et al.
Publicado: (2019)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure
por: Polyak, Stephen J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gn93oh41799j7007j0ib0drgip